Jersey health taxi spending climbs as patient travel rules face scrutiny
Health spending on taxis for Jersey patients travelling to Southampton has risen sharply, increasing from £140,594 in 2023 to £246,542 in 2025. The rise, disclosed through a freedom of information request, has placed patient travel policy under a brighter spotlight at a time when the island’s health budget is already under pressure.
The figures capture travel in areas around Southampton, where many Jersey patients are sent for care, and Health and Care Jersey has said they cannot be treated as a complete measure of taxi use for patients attending Southampton hospital alone. Even with that caveat, the trajectory is hard to ignore: spending rose by more than three quarters in two years.
The numbers also expose a deeper administrative question. When does transport support become a necessary clinical accommodation, and when does it become a cost the system can no longer absorb without tighter control?
Policy rules allow taxis when public transport is not realistic
Jersey’s patient travel policy says travel from a port to a UK hospital should normally use services contracted by Health and Care Jersey. If that is not possible, patients are expected to use public transport and claim reimbursement through the Travel Office.
A taxi or hire car can be approved when there is a medical reason, or when using other transport is not “possible or practical.” In other words, the policy already contains a built-in safety valve for patients whose condition, mobility, timing or journey complexity makes standard public transport unsuitable. For frail patients, people with reduced mobility, postoperative discomfort, or those facing long and complicated transfers, that discretion is not cosmetic. It is the difference between a tolerable transfer and a clinically burdensome one.
Still, the scale of spending suggests that the threshold for taxi approval, the volume of eligible patients, or both, may have shifted enough to matter to the public purse.
Budget pressure is forcing a closer look at travel support
The review comes after patient travel costs were described as “very generous” by a Health Board leader. Following that intervention, Health Minister Tom Binet said he would consider whether UK travel should continue to be paid for all patients in all circumstances.
His comments point to a policy debate that sits between equity and sustainability. Patients need access to care beyond Jersey, but the island must also decide how far it can go in underwriting every element of that journey. The minister said the health budget is under growing pressure and that resources must be used as effectively as possible. Officers, he added, are working to ensure current spending represents value for money.
That tension is familiar in small health systems that rely on off-island referrals. Travel is not peripheral to care delivery; it is part of the treatment pathway. Once patients are sent hundreds of miles for specialist services, transport becomes an operational cost, a patient safety issue, and a political problem all at once.
The rise in spending does not stand alone
The taxi figures arrive in a period of wider reassessment of patient travel policy. The change in tone from routine reimbursement to sharper scrutiny suggests that travel support, once treated as a predictable administrative necessity, is now being examined as a major budget line.
For patients, the policy wording still matters more than the headline number. The current rules leave room for clinical judgment. A taxi may be approved when it is not practical to use public transport, or when medical circumstances make that the safer option. That matters for people who may be immunocompromised, in pain, recovering from procedures, or unable to manage complex journeys through public transport networks and port transfers. The policy appears designed to prevent cost control from overriding basic clinical common sense.
At the same time, the leap from £140,594 in 2023 to £246,542 in 2025 raises straightforward questions about consistency. Are more patients being referred? Are more journeys being approved by taxi rather than scheduled transport? Has demand changed because of hospital scheduling, patient complexity, or a broader shift in how travel needs are assessed? Those answers are not in the current figures, but they will determine whether the spending pattern reflects legitimate clinical need or a system that has drifted into automatic approval.
What the figures reveal about system design
Health and Care Jersey said the data cover travel around Southampton and should not be read as a complete account of taxi spending for Southampton hospital alone. Even so, the disclosed amounts are large enough to force a policy review, especially when paired with concern over the overall health budget.
The most important point is not simply that taxi spending rose. It is that a transport policy intended to support access to care is now being judged through a financial lens because the numbers have moved so quickly. In small jurisdictions, that pressure often arrives before any formal service redesign. A few high-cost pathways can reshape spending faster than the system can explain it.
For clinicians, patient transport is rarely an abstract issue. A delayed or unsuitable journey can worsen symptoms, increase fatigue, and make an already difficult hospital visit more distressing. For administrators, however, every taxi booked under medical exception criteria becomes evidence that the default travel model is no longer sufficient for the demands being placed on it.
The next step is not a clinical trial or a new treatment protocol. It is a policy decision, and the missing detail is whether Jersey wants to narrow eligibility, expand shared transport, or preserve current arrangements despite the cost. Until that is settled, the taxi bill will remain a visible marker of how the island balances access, comfort and fiscal restraint.